AS THE PHARMACEUTICAL INDUSTRY CONTINUES ON ITS PATH OF RAPID DIGITISATION ( ONE WHICH COMES WITH SIGNIFICANT REWARDS , INCLUDING FASTER BREAKTHROUGHS AND INCREASED EFFICIENCY ), CYBERSECURITY WILL ONLY BECOME MORE IMPORTANT .
I N D U S T R Y I N V E S T I G A T I O N it is critical that companies manage identity and permissions to effectively protect sensitive data .
Of course , organisations in the sector can ’ t be expected to build up the expertise necessary to implement those things themselves . Their focus is , and should always be , on the business of drug development .
Instead , they should look to use cybersecurity providers with deep sector expertise , particularly when it comes to protecting business-critical applications . These applications impact everything from R & D , supply chain , to manufacturing and finance . That vendor should also have a strong track record when it comes to research , with its team able to proactively identify the latest threats and how to neutralise them .
The vendor should additionally be open about sharing research with customers ,
AS THE PHARMACEUTICAL INDUSTRY CONTINUES ON ITS PATH OF RAPID DIGITISATION ( ONE WHICH COMES WITH SIGNIFICANT REWARDS , INCLUDING FASTER BREAKTHROUGHS AND INCREASED EFFICIENCY ), CYBERSECURITY WILL ONLY BECOME MORE IMPORTANT .
ensuring that their own cybersecurity teams are able to deal with any new threats , identify any gaps across the attack surface and shore up any vulnerabilities .
Beyond that , the cybersecurity vendor should be able to help shore up an organisation ’ s response to a successful breach , ensuring business continuity . The better an organisation can respond to a successful attack , the lower the damage and fallout will be .
Adapting cybersecurity to a changing industry
As the pharmaceutical industry continues on its path of rapid digitisation ( one which comes with significant rewards , including faster breakthroughs and increased efficiency ), cybersecurity will only become more important .
As such , organisations in the sector must invest in cybersecurity , fortify critical applications , and manage data permissions .
In doing so , especially in concert with the right vendors , pharmaceutical organisations can safeguard their assets and effectively mitigate the impacts of cybercrime in an increasingly digital landscape . �
www . intelligenthealth . tech 43